Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07569471
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in PsychosisUniversity of TorontoRecruitingNot Applicable
NCT07569471Recruiting
Not Applicable
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach...University of Toronto
NCT07569497
Physical Activity Maintenance Intervention for People With StrokeNorthern Ireland Chest Heart and StrokeActive Not RecruitingNot Applicable
NCT07569497Active Not Recruiting
Not Applicable
Physical Activity Maintenance Intervention for People With StrokeNorthern Ireland Chest He...
NCT07571707
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General AnesthesiaUdayana UniversityRecruitingNot Applicable
NCT07571707Recruiting
Not Applicable
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing Genera...Udayana University
NCT07570212
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersChangping LaboratoryRecruitingNot Applicable
NCT07570212Recruiting
Not Applicable
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersChangping Laboratory
NCT07570563
Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Malignant Tumors.Chinese PLA General HospitalRecruitingPhase 1
NCT07570563Recruiting
Phase 1
Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Maligna...Chinese PLA General Hospi...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07569939
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisUniversity Hospital, Clermont-FerrandNot Yet RecruitingNot Applicable
NCT07569939Not Yet Recruiting
Not Applicable
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/o...University Hospital, Cler...
NCT07568704
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, IncRecruiting
NCT07568704Recruiting
—
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, Inc
NCT07569042
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed GlioblastomaNovelwise Pharmaceutical CorporationRecruitingPhase 1
NCT07569042Recruiting
Phase 1
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Ne...Novelwise Pharmaceutical...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07568782
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.Lille UniversityNot Yet Recruiting
NCT07568782Not Yet Recruiting
—
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Im...Lille University
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571005
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571005Not Yet Recruiting
Phase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07571213
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU AdmissionsRegion DalarnaCompleted
NCT07571213Completed
—
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National...Region Dalarna
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07568769
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of FaisalabadCompletedNot Applicable
NCT07568769Completed
Not Applicable
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of Faisalabad
NCT07568613
Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate CancerGerman Oncology Center, CyprusRecruitingNot Applicable
NCT07568613Recruiting
Not Applicable
Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Pr...German Oncology Center, C...
Result Breakdown
Recruiting10 (50%)
Not yet recruiting6 (30%)
Active, not recruiting2 (10%)
Completed2 (10%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 13 (15%)
Phase 22 (10%)
Phase 31 (5%)